ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan …
Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
14,589,134,848
Fair value reference
22.11
Next-week expectancy
Undecided · 47.69%
Executive chart read
Over the latest 12 completed weeks ending 2026-08-07, 1789 fell 0.94%, moving from 19.08 to 18.90. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -29.31 and has improved across the 12-week window. Market Dynamics is -0.28 on the latest week. Next-week expectancy is undecided at 47.69% based on similar historical setup states.
Week Ending
7 Aug 2026
Latest Close
18.90
12-Week Change
-0.94%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 47.69%
Signal Weeks
0 of 12
Weekly Price
Weekly Close
Trend Line
Fair Value
Activity Lines
Chart Panels
Choose up to 5 panels. Drag panel headers to reorder.
Price Action
Up Week
Down Week
Trend Line
Pivotal Level / Resistance
Volume
Range
Sharemaestro Range
Where price is trading
The fitted range, accepted trading area and strongest price levels are calculated automatically from completed weekly market data.
Current stateInside accepted value
52-week position
20.9%
Low to high
Accepted price
16.88
Latest versus accepted: 11.96%
Fitted direction
Rising
0.23% per week
Range pressure
23/100
Lower pressure
Range condition
Normal
0.88× normal range
Range pressureCurrent range pressure · 50 is balanced
Weekly closeFitted rangeActivity ribbonEstimated activity at priceAutomatic level
Automatic structure
Strongest price levels
Support16.59
From price
-12.2%
Evidence
94/100
Touches
6
Support17.22
From price
-8.9%
Evidence
72/100
Touches
2
Support18.59
From price
-1.7%
Evidence
63/100
Touches
3
Resistance20.04
From price
6.0%
Evidence
87/100
Touches
4
Resistance21.10
From price
11.7%
Evidence
78/100
Touches
3
Current reading
What the range shows
Current positionInside accepted value
Price is at 20.9% of its latest 52-week range.
Fitted directionRising
The fitted centre line is moving +0.23% per week.
Range pressureLower pressure
The current pressure reading is 23/100; 50 is balanced.
Next structural level20.04
Resistance is 6.0% from the latest close with 87/100 evidence strength.
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Market Dynamics
Volume Action
Price Action
Market Dynamics
Rate of Change
0-1.5TopBottomRawCloseMarket Strength30W ROCVolume SupportPrice Action RibbonBuyFlip UpFlip Down
Price Cycle
Market Price Cycle
PC Activity Line
PC Trend Line
Next-State Map
Next-State Map
Historical one-week transition paths from similar completed-week states.
SMI
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
Week Ending
7 Aug 2026
Latest Close
18.90
12-Week Change
-0.94%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 47.69%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-29.31
Market Dynamics
-0.28
Over the latest 12 completed weeks ending 2026-08-07, 1789 fell 0.94%, moving from 19.08 to 18.90. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -29.31 and has improved across the 12-week window. Market Dynamics is -0.28 on the latest week. Next-week expectancy is undecided at 47.69% based on similar historical setup states.
Industry Peers
Taiwan equities in Drug Manufacturers - Specialty & Generic
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.
